Operating Lease, Right-of-Use Asset of Avidity Biosciences, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Avidity Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • Avidity Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $52,848,000, a 739% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Avidity Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $52,848,000 +$46,549,000 +739% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $4,227,000 -$2,740,000 -39% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $4,929,000 -$2,696,000 -35% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $5,619,000 -$2,652,000 -32% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $6,299,000 -$2,608,000 -29% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $6,967,000 -$788,000 -10% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $7,625,000 -$634,000 -7.7% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $8,271,000 -$484,000 -5.5% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $8,907,000 -$357,000 -3.9% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $7,755,000 -$1,992,000 -20% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $8,259,000 -$1,998,000 -19% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $8,755,000 -$2,029,000 -19% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $9,264,000 +$9,219,000 +20487% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $9,747,000 +$9,565,000 +5255% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $10,257,000 +$9,939,000 +3125% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $10,784,000 +$10,330,000 +2275% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $45,000 -$328,000 -88% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $182,000 -$301,000 -62% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $318,000 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $454,000 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $373,000 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $483,000 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.